[Prednisolone sensitivity in patients with tumors of the diencephalo-hypophyseal region].
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000236:Adenoma / Q000150:complications*; D000239:Adenoma, Acidophil / Q000150:complications*; D000238:Adenoma, Chromophobe / Q000150:complications*; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000309:Adrenal Insufficiency / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D000324:Adrenocorticotropic Hormone; D001932:Brain Neoplasms / Q000150:complications*; D003397:Craniopharyngioma / Q000150:complications*; D004027:Diencephalon / Q000187:drug effects*; D004804:Eosinophils; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications; D007958:Leukocyte Count; D008297:Male; D008579:Meningioma / Q000150:complications*; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications*; D011239:Prednisolone / Q000008:administration & dosage*; D012658:Sella Turcica
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone
Issledovanie chuvstvitel'nosti k prednizolonu u bol'nykh s opukholiami diéntsefal'no-gipofizarnoi oblasti.